MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CTKB has $461,542K in assets. $119,803K in debts. $90,853K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
503.82%
Quick Ratio
441.58%
Cash Ratio
116.77%
Debt to Asset Ratio
25.96%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Trade accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, current
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
90,853
Restricted cash
0
Marketable securities
170,676
Trade accounts receivable, net
62,509
Inventories
48,428
Prepaid expenses and other current assets
19,530
Total current assets
391,996
Deferred income tax assets, noncurrent
0
Property and equipment, net
18,009
Operating lease right-of-use assets
11,315
Goodwill
16,697
Intangible assets, net
16,821
Other noncurrent assets
6,704
Total assets
461,542
Trade accounts payable
6,410
Legal settlement liability, current
2,495
Accrued expenses
23,417
Other current liabilities
16,978
Deferred revenue, current
28,504
Total current liabilities
77,804
Legal settlement liability, noncurrent
6,786
Deferred revenue, noncurrent
18,339
Operating lease liability, noncurrent
14,042
Long term debt
525
Other noncurrent liabilities
2,307
Total liabilities
119,803
Common stock, 0.001 par value 1,000,000,000 authorized shares as of december31, 2025 and december31, 2024, respectively 128,550,136 and 129,205,901 issued and outstanding shares as of december31, 2025 and december31, 2024, respectively
129
Additional paid-in capital
441,107
Accumulated deficit
-101,738
Accumulated other comprehensive income
2,241
Total stockholders equity
341,739
Total liabilities and stockholders equity
461,542
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$170,676K Cash and cashequivalents$90,853K Trade accountsreceivable, net$62,509K Inventories$48,428K Prepaid expenses andother current assets$19,530K Total current assets$391,996K Property and equipment,net$18,009K Intangible assets, net$16,821K Goodwill$16,697K Operating leaseright-of-use assets$11,315K Other noncurrentassets$6,704K Total assets$461,542K Total liabilities andstockholders equity$461,542K Total stockholdersequity$341,739K Total liabilities$119,803K Accumulated deficit-$101,738K Additional paid-in capital$441,107K Total currentliabilities$77,804K Deferred revenue,noncurrent$18,339K Operating leaseliability, noncurrent$14,042K Legal settlementliability, noncurrent$6,786K Other noncurrentliabilities$2,307K Long term debt$525K Accumulated othercomprehensive income$2,241K Common stock, 0.001 parvalue 1,000,000,000...$129K Deferred revenue,current$28,504K Accrued expenses$23,417K Other currentliabilities$16,978K Trade accountspayable$6,410K Legal settlementliability, current$2,495K

Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences, Inc. (CTKB)